These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 23852602)

  • 1. Reconstituting the NLRP1 inflammasome in vitro.
    Faustin B; Reed JC
    Methods Mol Biol; 2013; 1040():137-52. PubMed ID: 23852602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NLRP1 inflammasomes.
    Chavarría-Smith J; Vance RE
    Immunol Rev; 2015 May; 265(1):22-34. PubMed ID: 25879281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation.
    Faustin B; Lartigue L; Bruey JM; Luciano F; Sergienko E; Bailly-Maitre B; Volkmann N; Hanein D; Rouiller I; Reed JC
    Mol Cell; 2007 Mar; 25(5):713-24. PubMed ID: 17349957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.
    Kaushal V; Dye R; Pakavathkumar P; Foveau B; Flores J; Hyman B; Ghetti B; Koller BH; LeBlanc AC
    Cell Death Differ; 2015 Oct; 22(10):1676-86. PubMed ID: 25744023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical regulation of the inflammasome.
    Dowling JK; O'Neill LA
    Crit Rev Biochem Mol Biol; 2012 Sep; 47(5):424-43. PubMed ID: 22681257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput screening identifies ATP-competitive inhibitors of the NLRP1 inflammasome.
    Harris PA; Duraiswami C; Fisher DT; Fornwald J; Hoffman SJ; Hofmann G; Jiang M; Lehr R; McCormick PM; Nickels L; Schwartz B; Wu Z; Zhang G; Marquis RW; Bertin J; Gough PJ
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2739-43. PubMed ID: 26022841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nlrp1 inflammasome is downregulated in trauma patients.
    Relja B; Horstmann JP; Kontradowitz K; Jurida K; Schaible A; Neunaber C; Oppermann E; Marzi I
    J Mol Med (Berl); 2015 Dec; 93(12):1391-400. PubMed ID: 26232934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease.
    Saresella M; La Rosa F; Piancone F; Zoppis M; Marventano I; Calabrese E; Rainone V; Nemni R; Mancuso R; Clerici M
    Mol Neurodegener; 2016 Mar; 11():23. PubMed ID: 26939933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of NLRP inflammasome on the regulation of AGEs-induced inflammatory response in human periodontal ligament cells.
    Yi X; Zhang L; Lu W; Tan X; Yue J; Wang P; Xu W; Ye L; Huang D
    J Periodontal Res; 2019 Dec; 54(6):681-689. PubMed ID: 31250434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NLRP1 Inflammasome in Human Skin and Beyond.
    Fenini G; Karakaya T; Hennig P; Di Filippo M; Beer HD
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes.
    Maier NK; Leppla SH; Moayeri M
    J Immunol; 2015 Mar; 194(6):2776-85. PubMed ID: 25681332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammasomes: guardians of cytosolic sanctity.
    Lamkanfi M; Dixit VM
    Immunol Rev; 2009 Jan; 227(1):95-105. PubMed ID: 19120479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteins.
    MacDonald JA; Wijekoon CP; Liao KC; Muruve DA
    IUBMB Life; 2013 Oct; 65(10):851-62. PubMed ID: 24078393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus.
    Liu H; Xu R; Kong Q; Liu J; Yu Z; Zhao C
    Biomed Pharmacother; 2017 Oct; 94():619-626. PubMed ID: 28783585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NLRP1 and NLRP3 inflammasomes contributed to cyclic stretch-induced pyroptosis and release of IL-1β in human periodontal ligament cells.
    Zhao D; Wu Y; Zhuang J; Xu C; Zhang F
    Oncotarget; 2016 Oct; 7(42):68292-68302. PubMed ID: 27626170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms involved in inflammasome activation.
    Bryant C; Fitzgerald KA
    Trends Cell Biol; 2009 Sep; 19(9):455-64. PubMed ID: 19716304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biophysical Characterisation and SAXS Analysis of Human NLRP1 Uncover a New Level of Complexity of NLR Proteins.
    Martino L; Holland L; Christodoulou E; Kunzelmann S; Esposito D; Rittinger K
    PLoS One; 2016; 11(10):e0164662. PubMed ID: 27727326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.
    Zhong FL; Robinson K; Teo DET; Tan KY; Lim C; Harapas CR; Yu CH; Xie WH; Sobota RM; Au VB; Hopkins R; D'Osualdo A; Reed JC; Connolly JE; Masters SL; Reversade B
    J Biol Chem; 2018 Dec; 293(49):18864-18878. PubMed ID: 30291141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a viral NLR homolog that inhibits the inflammasome.
    Gregory SM; Davis BK; West JA; Taxman DJ; Matsuzawa S; Reed JC; Ting JP; Damania B
    Science; 2011 Jan; 331(6015):330-4. PubMed ID: 21252346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus.
    Yang Q; Yu C; Yang Z; Wei Q; Mu K; Zhang Y; Zhao W; Wang X; Huai W; Han L
    J Rheumatol; 2014 Mar; 41(3):444-52. PubMed ID: 24334646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.